SCHEMBL17599403

SCHEMBL17599403

Cc1c(Cl)cccc1S(=O)(=O)Nc1ccc(-c2cccc(C(=O)O)c2)c2ccccc12

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
WDR5 P61964 2/20 0.49
PTK2B Q14289 2/20 0.48
KDM4E B2RXH2 1/20 0.48
TSHR P16473 1/20 0.48
PFKFB4 Q16877 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
FABP4 P15090 1/20 0.45
HSD11B1 P28845 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
KMT2A Q03164 2/20 0.45
ACLY P53396 2/20 0.45
MEN1 O00255 1/20 0.44
TDP1 Q9NUW8 1/20 0.43
MCL1 Q07820 1/20 0.43
SLC40A1 Q9NP59 1/20 0.43
SLC16A3 O15427 2/20 0.42
EDNRB P24530 1/20 0.42
EDNRA P25101 1/20 0.42
BRD4 O60885 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17599379 0.89 ACLY (0.54) WDR5PTK2BKDM4ETSHRSMN1; SMN2
SCHEMBL17599319 0.88 ACLY (0.46) WDR5PTK2BKDM4ETSHRSMN1; SMN2
SCHEMBL17599371 0.87 KMT2A (0.51) WDR5PTK2BKDM4ETSHRSMN1; SMN2
SCHEMBL17599368 0.85 KDM4E (0.48) WDR5PTK2BKDM4ETSHRPFKFB4
SCHEMBL17599404 0.84 KMT2A (0.48) WDR5FABP4L3MBTL1KMT2AACLY
SCHEMBL17599340 0.84 SLC16A3 (0.58) WDR5PTK2BKDM4ETSHRSMN1; SMN2
SCHEMBL17599360 0.84 ITGA1 (0.56) WDR5PTK2BKDM4ETSHRSMN1; SMN2
SCHEMBL17599382 0.83 WDR5 (0.45) WDR5PTK2BKDM4ETSHRFABP4
SCHEMBL17599361 0.83 KDM4E (0.43) WDR5PTK2BKDM4ETSHRPFKFB4
SCHEMBL17599310 0.82 PTK2B (0.53) WDR5PTK2BKDM4ETSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2998294-A1 Naphthyl sulfonamide phenyl derivatives as KEAP-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders SANOFI (FR) 2016-03-23 EP disclosed
EP-2998294-A1 Naphthyl sulfonamide phenyl derivatives as KEAP-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders SANOFI (FR) 2016-03-23 EP disclosed